As a proof of concept, PDC*line cells were loaded with two NeoAgs (ME-1 and AKAP13, Table 1) already described in melanoma and lung cancer patients [28, 68] and two commonly shared tumor-associated antigens as positive controls (gp100, CAMEL). Here, PDC is linked to neoplasm.